TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.180
+0.040 (3.51%)
At close: Jan 22, 2026, 4:00 PM EST
1.160
-0.020 (-1.69%)
After-hours: Jan 22, 2026, 6:39 PM EST
TScan Therapeutics Employees
As of December 31, 2024, TScan Therapeutics had 195 total employees, including 194 full-time and 1 part-time employees. The number of employees increased by 41 or 26.62% compared to the previous year.
Employees
195
Change (1Y)
41
Growth (1Y)
26.62%
Revenue / Employee
$43,195
Profits / Employee
-$731,272
Market Cap
66.96M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 195 | 41 | 26.62% | 194 | 1 |
| Dec 31, 2023 | 154 | 16 | 11.59% | 154 | 0 |
| Dec 31, 2022 | 138 | 33 | 31.43% | 137 | 1 |
| Dec 31, 2021 | 105 | 47 | 81.03% | 104 | 1 |
| Dec 31, 2020 | 58 | - | - | 57 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 124 |
| Adlai Nortye | 123 |
| Acrivon Therapeutics | 78 |
| ImmuCell | 75 |
| InflaRx | 74 |
| aTyr Pharma | 65 |
| BeyondSpring | 40 |
| Equillium | 35 |
TCRX News
- 7 weeks ago - TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities - GlobeNewsWire
- 2 months ago - TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 2 months ago - TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027 - GlobeNewsWire
- 4 months ago - TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025 - GlobeNewsWire
- 5 months ago - TScan Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - TScan Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 8 months ago - TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference - GlobeNewsWire